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Background: Primary nonadherence to prescribed medications occurs when patients do 
not fill or dispense prescriptions written by healthcare providers. Although it has become 
an important public health issue in recent years, little is known about its frequency, 
causes, and consequences. Moreover, the pattern of risk factors shows remarkable 
variability across countries according to the published results. Our study aimed to assess 
primary nonadherence to medications prescribed by general practitioners (GPs) and its 
associated factors among adults in Hungary for the period of 2012–2015.
Methods: Data on all general medical practices (GMPs) of the country were obtained 
from the National Health Insurance Fund and the Central Statistical Office. The ratio of 
the number of dispensed medications to the number of prescriptions written by a GP 
for adults was used to determine the medication adherence, which was aggregated 
for GMPs. The effect of GMP characteristics (list size, GP vacancy, patients’ education 
provided by a GMP, settlement type [urban or rural], and geographical location [by county] 
of the center) on adherence, standardized for patients’ age, sex, and eligibility for an 
exemption certificate, were investigated through generalized linear regression modeling.
Results: A total of 281,315,386 prescriptions were dispensed out of 438,614,000 
written by a GP. Overall, 64.1% of prescriptions were filled. According to the generalized 
linear regression coefficients, there was a negative association between standardized 
adherence and urban settlement type (b = ‑0.099, 95%CI = ‑0.103 to ‑0.094), higher 
level of education (b = ‑0.440, 95%CI = ‑0.468 to ‑0.413), and vacancy of the general 
practices (b = ‑0.193, 95%CI = ‑0.204 to ‑0.182). The larger GMP size proved to be a risk 
factor, and there was a significant geographical inequality for counties as well.
Abbreviations: ATC, Anatomical Therapeutic Chemical; b, unstandardized regression coefficient; CI, Confidence interval; 
DWR, dispensed to written ratio; GMP, General medical practice; GP, General practitioner; NHIF, National Health Insurance 
Fund; SDWR, standardized dispensed to written ratio; WHO, World Health Organization.
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Conclusions: More than one‑third of the written prescriptions of GPs for adults in Hungary 
were not dispensed. This high level of nonadherence had great variability across GMPs, 
and can be explained by structural characteristics of GMPs, the socioeconomic status of 
patients provided, and the quality of cooperation between patients and GPs. Moreover, our 
findings suggest that the use of the dispensed‑to‑prescribed medication ratio in routine 
monitoring of primary health care could effectively support the necessary interventions.
Keywords: medication adherence, dispensed prescriptions, urbanization, level of education, GP vacancy, GMP 
size, geographical inequality, exemption certificate
INTRODUCTION
Recently, the concept of adherence to medication has gained 
increasing attention (Ho et al., 2009; Lee et al., 2018) and has become 
an important public health issue (Balkrishnan, 2005; Fischer et al., 
2010). The WHO recommends the use of the dispensed proportion 
of prescribed drugs, the primary adherence to medication, as a basic 
indicator of health care operation (World Health Organization, 
1993). Indeed, medication adherence is considered the cornerstone 
in the management, control, and prevention of loss of the desired 
therapeutic outcome, disease progression, and complications (De 
Simoni et al., 2013; Colombo et al., 2016; Nielsen et al., 2017). 
Several studies attributed higher morbidity and mortality among 
patients to medication nonadherence (Ho et al., 2006a; Ho et al., 
2006b; Aronson, 2007; Gwadry-Sridhar et al., 2013). In addition, 
nonadherence increases healthcare cost and hospitalization and is 
associated with deterioration of the quality of life (Osterberg and 
Blaschke, 2005; Sokol et al., 2005; Brown and Bussell, 2011; Raebel 
et al., 2012; Kardas, 2013).
Nonadherence is a global issue (Cramer, 2004; Stankuniene 
et al., 2012; Kleinsinger, 2018). A meta-analysis of 20 studies 
conducted between 1998 and 2010 in Australia, Canada, the USA, 
and Europe to assess the extent of adherence of cardiovascular 
patients to their regimens indicated that approximately 50% were 
not properly adherent to cardiovascular medications prescribed 
for preventive purposes (Naderi et al., 2012). However, a 
meta-analysis of hundreds of studies conducted over a 50-year 
period reported that, on average, approximately one-fourth 
of the patients did not adhere to their regimens (DiMatteo, 
2004). Furthermore, a study conducted in Canada in primary 
healthcare between 2006 and 2009 reported that 31.3% of the 
written prescriptions were not filled (Tamblyn et al., 2014). In 
2018, an extensive meta-analysis conducted to measure primary 
nonadherence to medications of chronic diseases reported a 
nonadherence rate of 14.6% (Lemstra et al., 2018).
Several factors have been identified to affect patient adherence 
to prescribed regimens (Lee et al., 2017; Lee et al., 2018). 
Those factors include patients’ demographic (age and sex) and 
socioeconomic status (e.g., education, income, and social support) 
(Krousel-Wood et al., 2004; Park et al., 2008; Peek et al., 2016; 
Boruzs et al., 2016; Nashilongo et al., 2017). In addition, patients’ 
cognitive ability, expectations, beliefs, attitude, comorbidities, 
and poly-pharmacy were reported to be major determinants 
(Vermeire et al., 2001; Mardby et al., 2007; Ferdinand et al., 
2017; Rampamba et al., 2018). Furthermore, factors linked to the 
healthcare system (Kardas et al., 2013; Granger et al., 2015) and 
treatment-related issues (side effects and therapy duration) were 
found to affect levels of adherence (Fried et al., 2011).
Some interventions tested globally to enhance adherence 
included simple dose adjustment and reduction of the number 
of medications (Burke et al., 1997; Schedlbauer et al., 2010), 
reminders and improved scheduling (Claxton et al., 2001), and 
educational interventions (Kuntz et al., 2014; Torres-Robles 
et al., 2018). Other interventions included more comprehensive 
and complex strategies, such as expansion of the pharmacist 
role in health care, enhancement of patient–health care provider 
communication and trust, provision of services (Lu et al., 2008; 
Banning, 2009), proper description of disease and medications 
(Osterberg and Blaschke, 2005; Huang et al., 2017), habit analysis 
and management of side effects (Omran et al., 2012; Conn and 
Ruppar, 2017), patient follow-up, social and behavioral support 
and motivation (DiMatteo et al., 2012; Varshney, 2013; Kuntz 
et  al., 2014; Ferdinand et al., 2017), and acting on patients’ 
feedback (Farris et al., 2016).
Although adherence to medications is crucial for successful 
treatment strategies, less attention has been given to this issue 
until recently (Storm et al., 2008; Joyce, 2010). The lack of 
detailed knowledge on the frequency, causes, and consequences 
of nonadherence obstructs the elaboration of interventions 
(Fischer et al., 2010; Shin et al., 2012).
Nonadherence in Hungary has so far been little investigated. 
According to the self-reported data of the European Social Survey 
(Larsen et al., 2009), 18% of participants did not adhere precisely 
to the prescribed regimens in Europe. The nonadherence rate 
detected in this survey was 20.3% in Hungary. This fourth 
highest rate among the 24 surveyed countries (with reported 
rates ranging from 6.3% to 25.2%) suggests that nonadherence is 
of especially high importance in Hungary (Stavropoulou, 2011). 
It seems plausible that this relatively high nonadherence rate 
contributes to the relatively high amenable mortality in Hungary, 
which is 2.1 times higher than the average in the European Union, 
according to the EUROSTAT statistics for 2015 (Eurostat). Since 
the Hungarian primary health care performance is ranked in the 
weakest third in Europe (Kringos et al., 2013), general medical 
practices may be a potential target of intervention to improve 
adherence and thereby to improve the public health status in 
the country. It is worth mentioning that the health insurance 
in Hungary, provided by the National Health Insurance Fund 
(NHIF), covers more than 96% of the population. The costs of 
medicines are shared by the NHIF and the patient by a health 
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insurance scheme. Due to this cost sharing, patients are not 
motivated to hide any drug consumption from the NHIF (Gaál 
et al., 2011). Thus, its data on prescribed and dispensed drugs are 
reliable and can be used to assess adherence to medications in a 
nationally representative manner.
The aims of this study were 1) to describe adherence to 
general practitioner (GP)-prescribed medications among 
Hungarian adults by quantifying the dispensed proportion of 
prescribed medications, 2) to describe the variability of this 
adherence across general medical practices, and 3) to assess the 
influence of general medical practices’ structure and patients’ 
characteristics on that variability. For this study, we hypothesized 
that nonadherence to GP-prescribed medications among adults 
in Hungary is related to patients’ characteristics (age, sex, 
eligibility for exemption certificate) and general medical practice 
characteristics such as socioeconomic status of adults provided 
(indicated by standardized relative education), list size of general 
medical practice, GP vacancy, type of settlement, and location by 
county where general medical practice is located.
METHODS
Setting
This study was a secondary database analysis. The unit of analysis 
was the prescription written by a GP and dispensed by patients. 
Data on written and dispensed prescriptions were obtained from the 
NHIF. All general medical practices (GMPs) operating in Hungary 
were investigated. The available data covered the period from the 
beginning of 2012 until the end of the third quarter of 2015.
Data
These data were stratified by age (5-year bands), sex, and possession 
of exemption certificate. Drugs were classified according to 
the Anatomical Therapeutic Chemical (ATC) Classification 
recommended by the WHO (WHO Collaborating Center for 
Drug Statistics Methodology). ATC groups of “Antineoplastic 
and immunomodulating agents” and “Antiparasitic products, 
insecticides, and repellents” were not included in the analyses 
because the use of these drugs is not connected to GPs according 
to the Hungarian regulations.
The NHIF also provided data on the characteristics of GMPs. 
GMPs were described by the number of adults for which care 
was provided using the official categorization of the NHIF 
(less than 800, 801–1,200, 1,201–1,600, 1,601–2,000, and 2,001 
or more patients). GMPs were also categorized as having a 
vacant or filled GP position (provided by a temporary GP with 
availability restricted in time and place or by a permanent 
contracted GP with continuous availability). Rural or urban 
GMPs were distinguished. GMPs were classified according to 
their geographical location by county.
The socioeconomic status of the adults receiving care at 
each GMP was approximated by the sex- and age-internally 
standardized relative education. This indicator was computed 
by indirect method, using sex and age group-specific levels of 
education from the 2011 Hungarian Census and the sex and age 
group composition of GMP clients (Janka et al., 2018). Since 
internal standardization was applied, the national average of 
socioeconomic status corresponds to value 1 of standardized 
relative education.
Statistical Analysis
The sex-, age-, and exemption certificate-specific number of 
written and dispensed prescriptions and the percentage of drugs 
actually dispensed (dispensed to written ratio, DWR) as the 
indicator for medication adherence (World Health Organization, 
1993) were determined by the NHIF for the whole country for 
the investigated period. These national reference DWRs were 
calculated for each studied ATC group. NHIF data on prescribed 
and dispensed drugs are reliable and the statistical power could 
be ensured by the applied design being strong.
Our dependent variables were adherence ratios indirectly 
standardized for age, sex, and exemption certificate. These 
standardized adherence ratios were calculated by dividing the 
agregated GMP-specific numbers of the observed dispensed 
prescriptions by the aggregated GMP-specific numbers of 
expected dispensed prescriptions.
Using the sex-, age-, and exemption certificate-specific number 
of written prescriptions by GMP and the national reference DWRs, 
the expected number of dispensed prescriptions was calculated 
for each GMP (summarizing the expected number of dispensed 
prescriptions across strata). The ratio of the registered number of 
filled prescriptions in a GMP and the calculated GMP-specific 
expected number of dispensed prescriptions was computed as the 
GMP-specific standardized DWR (SDWR) for each ATC group.
The distributions of the ATC group-specific and the general 
SDWR values computed for GMP were not normal according to 
Kolmogorov–Smirnov testing (Supplementary Appendix 14). 
Median values and interquartile ranges were used to describe 
their distribution. Taking into consideration that calculated 
SDWRs were positive numbers, Box–Cox transformation 
was applied to normalize the SDWRs (Curran-Everett, 2018) 
(histograms for original and transformed SDWR parameters are 
in Supplementary Appendix 15).
To identify the factors that influence the SDWR by controlling 
for the time, we conducted generalized linear modeling. 
Linear regression coefficients (b) with the corresponding 95% 
confidence interval (95%CI) were calculated. In the model, GP 
vacancy and settlement type were used as binary parameters, and 
county location and GMP size were used as dummy variables 
with reference categories of Budapest and GMP size of 1,601–
2,000 persons, respectively. This analysis was also conducted for 
each ATC group. Pearson’s chi-square goodness-of-fit test was 
applied to describe the performance of regression modeling.
The level of significance was fixed at 95% (p < 0.05). SPSS 
version 20 was used in the data analysis.
RESUlTS
The distribution of characteristics for the 4,856 GMPs investigated 
is summarized in Table 1. Of the studied GMPs, 3.30% were 
vacant, and 34.70% were in rural areas. The majority of GMPs 
provided care to 1,201–1,600 (30.5%) or 1,601–2,000 (31.7%) 
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adults. Due to the internal approach of indirect standardization, 
the mean relative education of the provided population was 1.00 
(SD ± 0.10).
In general, the observed DWR was 64.1% (Table 2). There 
was only a slight difference between men (63.6%) and women 
(64.5%). Age showed considerable influence. The lowest DWR was 
registered for middle-aged adults (62.1%). The highest was detected 
among adults with exemption certificates (78.3%). Regarding sex 
and exemption certificate, the same pattern was observed for each 
ATC group, while the age dependency of the DWR varied by ATC 
group (details in Supplementary Appendices 1–12).
There was wide variability of the DWR by drug class (Table 3). 
The lowest DWR was registered for cardiovascular system drugs 
at 59.4%. The highest value was 79.1%, reported for the anti-
infective drugs for systemic use.
The SDWRs varied over a wide range. The limits of the 
interquartile range were 0.87 and 1.22. The interquartile ranges 
for the ATC groups varied between 0.14 (anti-infectives for 
systemic use) and 0.42 (cardiovascular system agents) apart from 
the various (ATC V) groups (Supplementary Appendix 13).
An inverse association was found between normalized 
SDWRs (D = 0.002; p = 0.200 according to the Kolmogorov–
Smirnov test as presented in Supplementary Appendix 14) 
and the relative education of the adult population that received 
care (b = -0.440, 95%CI = -0.468 to -0.413), vacancy of GP (b = 
-0.193, 95%CI = -0.204 to -0.182), and urban residential place 
(b  =  -0.099, 95%CI  = -0.103 to -0.094). The size of the GMP 
proved to be a significant influencing factor. A relatively higher 
TABlE 3 | Dispensed to written prescription ratio by ATC group in Hungary in the period from 1 January 2012 to 30 September 2015.
Written prescriptions Dispensed prescriptions Percentage of the dispensed prescriptions
Alimentary tract and metabolism 71,736,340 49,208,724 68.6
Blood and blood forming organs 30,237,857 20,921,060 69.2
Cardiovascular system 228,225,210 135,489,086 59.4
Dermatologicals 4,382,185 2,707,111 61.8
Genitourinary system and sex hormones 3,396,924 2,289,588 67.4
Systemic hormonal preparations* 4,822,082 3,570,757 74.1
Antiinfectives for systemic use 13,348,380 10,559,995 79.1
Musculoskeletal system 29,820,787 20,541,099 68.9
Nervous system 28,337,910 20,040,657 70.7
Respiratory system 21,830,141 14,357,120 65.8
Sensory organs 1,626,640 1,113,623 68.5
Various 849,544 516,566 60.8
Altogether^ 438,614,000 281,315,386 64.1
*Excluding sex hormones and insulin.
^ATC groups of “Antineoplastic and immunomodulating agents” and “Antiparasitic products, insecticides, and repellents” were not studied.
TABlE 1 | Distribution of general medical practice (GMP) characteristics in Hungary.
Variable name Number of GMP (%)
Vacancy of general practitioner Vacant 160 (3.3)
Fulfilled 4,696 (96.7)
Type of settlement Rural 1,683 (34.7)
Urban 3,173 (65.3)
Size of GMP <800 158 (3.3)
800–1,200 677 (13.9)
1,201–1,600 1,481 (30.5)
1,601–2,000 1,541 (31.7)
> 2,000 999 (20.6)
County Budapest 875 (18)
Baranya 209 (4.3)
Bács‑Kiskun 256 (5.3)
Békés 191 (3.9)
Borsod‑Abaúj‑Zemplén 377 (7.8)
Csongrád 205 (4.2)
Fejér 196 (4)
Gyo˝r 205 (4.2)
Hajdú‑Bihar 246 (5.1)
Heves 161 (3.3)
Komárom‑Esztergom 146 (3)
Nógrád 109 (2.2)
Pest 477 (9.8)
Somogy 177 (3.6)
Szabolcs‑Szatmár‑Bereg 267 (5.5)
Jász‑Nagykun‑Szolnok 194 (4)
Tolna 121 (2.5)
Vas 134 (2.8)
Veszprém 169 (3.5)
Zala 141 (2.9)
Total number of GMPs 4,856 (100.0)
TABlE 2 | Dispensed to written prescription ratio by patient characteristics in Hungary in the period from 1 January 2012 to 30 September 2015.
Patient characteristics Written prescriptions Dispensed prescriptions Percentage of the dispensed prescriptions
Age groups (years) 18–44 39,971,036 25,539,871 63.9
45–64 171,996,562 106,753,470 62.1
65 and above 226,646,402 149,022,045 65.8
Sex Male 172,358,931 109,603,855 63.6
Female 266,255,069 171,711,531 64.5
Exemption certificate Yes 47,960,440 37,548,944 78.3
No 390,653,560 243,766,442 62.4
Total 438,614,000 281,315,386 64.1
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SDWR was observed in smaller GMPs (bX–800 = 0.052, 95%CI = 
0.041–0.063, b801–1200 = 0.031, 95%CI = 0.025–0.037, b1201–1600 = 
0.017, 95%CI = 0.013–0.022), while the larger GMPs showed a 
lower SDWR (b2001–X = -0.014, 95%CI = -0.019 to -0.009).
There was a significant impact of geographical location 
according to the county-specific regression coefficients (Table 4). 
According to the generalized linear regression coefficients, the 
urban residential place, high relative education, and vacant GP 
position (in decreasing effect size) are the stronger factors that 
reduce the GMP-level SDWR. This general pattern was observed 
for each studied ATC group (Supplementary Appendix 16).
DISCUSSION
Our investigation, which is the first population-based study in 
Hungary on medication nonadherence, found that only 64.1% of 
the medicines prescribed by a GP in Hungary are dispensed. This 
kind of adherence varies from 59.4% (cardiovascular systems’ 
agents) to 79.1% (anti-infectives for systemic use) by ATC groups. 
This registered nonadherence (35.9%) is higher than the levels 
of nonadherence observed in Canada (31.3%), Woonsocket, 
USA (24%), Massachusetts, USA (22.5%), Scotland (14.5%), and 
Sweden (2.4%) (Beardon et al., 1993; Ekedahl and Mansson, 2004; 
Fischer et al., 2010; Fischer et al., 2011; Tamblyn et al., 2014).
Gender has proven to be not an important determinant 
of nonadherence, while middle-aged adults are at risk of not 
dispensing prescribed medications. The strong protective role of 
eligibility for exemption certificates demonstrates the influence 
of patients’ socioeconomic status.
According to our regression models, the urban environment 
is a risk factor for nonadherence. There are publications with 
similar (Kim et al., 2016) and opposite (Park et al., 2008; 
Karakurt and Kasikci, 2012) conclusions. Certain elements of the 
urban lifestyle (better access to health services, better economic 
conditions, special working schedule, and urban attitude and 
beliefs) supposed to underlie these variable observations (Nair 
et  al., 2011; Lewis et al., 2012; Khan et al., 2014; Magnabosco 
et al., 2015; Boruzs et al., 2018) urge further investigations in 
Hungary as key obstacles to medication adherence.
Our study found a relatively strong negative association 
between education and the level of adherence. This finding is 
consistent with findings reported by the second round of the 
European Social Survey (Larsen et al., 2009), but there are 
publications on the positive association between education 
and medication adherence, as well (Karakurt and Kasikci, 
2012; Daniel and Veiga, 2013). A higher level of education 
can be an indicator of a better ability to perceive the benefit 
of GPs’ instructions (Mardby et al., 2007). However, the effect 
of education on adherence is complex (Isacson and Bingefors, 
2002), and not only knowledge but also the education-related 
attitude plays an important role (Andersen, 1995). Highly 
educated people hold themselves accountable for their own 
health (Hashimoto and Fukuhara, 2004) and are more critical 
towards GPs’ instructions (Gudjonsson and Sigurdsson, 
2003). Our observation could reflect a poor collaboration 
between patients and GPs, which counterbalances the better 
understanding of medications’ benefit.
Our study demonstrated the adherence-decreasing role of 
GP vacancies, when a permanent GP replacing the missing GP 
provides care. A similar finding was reported in South Korea 
(Park et al., 2008). This effect can be straightforwardly explained 
by the well-known importance of the continuity of care and trust 
in physicians (Rost et al., 1990; Hjortdahl and Laerum, 1992; 
Mainous et al., 2001). On the other hand, this result demonstrates 
that the workforce crisis in primary health care (resulting in 
increasing number of GP vacancies) exerts its detrimental effect 
on patients’ prognosis (Sandor et al., 2018) through reduced 
adherence to medication.
The importance of geographical inequalities in medication 
adherence (Couto et al., 2014; Di Martino et al., 2016) has been 
confirmed by our results. The county in our context can be 
considered a summary indicator of many spatially variable factors 
not related to urbanization, level of education, GP vacancy, or 
socioeconomic status (controlled by standardization for sex, age, 
and eligibility for an exemption certificate). The importance of the 
availability of health services, not controlled for our investigation, 
may be reflected in this observation (Tan et al., 2017). According 
to our results, this impact is less than the impact of GP vacancy, 
level of education, and urban living environment.
Our study could demonstrate the importance of the GMP list 
size: the more patients belong to a GMP, the lower the medication 
TABlE 4 | Generalized linear modeling^ on the associations between general 
medical practice (GMP) characteristics and normalized* age‑, gender‑, and 
exemption certificate‑standardized dispensed to written prescription ratios among 
Hungarian adults in the period from 1 January 2012 to 30 September 2015.
Regression coefficient [95%CI]
Standardized relative education** –0.440 [‑0.468; ‑0.413]
Vacant GP position/filled GP position –0.193 [‑0.204; ‑0.182]
Urban/rural –0.099 [‑0.103; ‑0.094]
X–800 GMP size/1,601–2,000 GMP size 0.052 [0.041; 0.063]
801–1,200 GMP size/1,601–2,000 GMP size 0.031 [0.025; 0.037]
1,201–1,600 GMP size/1,601–2,000 GMP size 0.017 [0.013; 0.022]
2,001–X GMP size/1,601–2,000 GMP size –0.014 [‑0.019; ‑0.009]
Baranya county/Budapest 0.083 [0.072; 0.093]
Bács‑Kiskun county/Budapest 0.056 [0.046; 0.067]
Békés county/Budapest 0.023 [0.012; 0.033]
Borsod‑Abaúj‑Zemplén county/Budapest –0.015 [‑0.024; ‑0.006]
Csongrád county/Budapest 0.021 [0.011; 0.032]
Fejér county/Budapest –0.132 [‑0.142; ‑0.121]
Gyo˝r‑Moson‑Sopron county/Budapest –0.002 [‑0.012; 0.008]
Hajdú‑Bihar county/Budapest –0.035 [‑0.045; ‑0.025]
Heves county/Budapest –0.033 [‑0.044; ‑0.021]
Jász‑Nagykun‑Szolnok county/Budapest 0.044 [0.033; 0.055]
Komárom‑Esztergom county/Budapest 0.072 [0.060; 0.084]
Nógrád county/Budapest –0.028 [‑0.042; ‑0.015]
Pest county/Budapest –0.002 [‑0.01; 0.006]
Somogy county/Budapest 0.079 [0.068; 0.09]
Szabolcs‑Szatmár‑Bereg county/Budapest 0.074 [0.064; 0.084]
Tolna county/Budapest 0.060 [0.047; 0.073]
Vas county/Budapest 0.103 [0.091; 0.115]
Veszprém county/Budapest 0.006 [‑0.006; 0.017]
Zala county/Budapest 0.017 [0.005; 0.029]
*Box–Cox transformation.
**Standardized continuous parameter.
^p = 0.060 (Pearson’s chi-square goodness-of-fit test).
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adherence. Taking into consideration that one GP and one nurse 
represent the typical staff in a Hungarian GMP (Gaál et al., 2011), 
this effect may be simply attributed to the less time that can be 
devoted to a patient.
Implications
The observed high medication nonadherence obviously 
contributes to the impaired prognosis of diseases that can be 
treated by medications available. Although this impact could not 
be quantified in this investigation, taking into consideration the 
59.4% observed adherence for cardiovascular diseases (which 
basically determines the life expectancy in European countries), 
this impact can be great, requiring further and more detailed 
studies and likely urging interventions.
On the other hand, the work, time, and capacities behind 
a prescription not filled contribute to the waste of resources 
in health care. Therefore, the observed nonadherence can also 
be considered an indicator of the effectiveness of patient–GP 
cooperation. The wide variability in GMP-level adherence 
we observed suggests that primary health care (PHC) teams 
have variable effectiveness in this respect. Furthermore, our 
results demonstrate that the role of GPs is especially weak in 
managing patients’ diseases among urban and higher educated 
adults. Consequently, the PHC monitoring system needs to be 
completed with primary medication adherence monitoring to 
identify GMPs to be improved and to benchmark the necessary 
interventions including, inter alia, educational interventions and 
improving patient physician relationship and communication.
STRENGTHS AND lIMITATIONS
The health insurance in Hungary, provided by the NHIF, covers 
more than 96% of the population. The costs of medicines 
are shared by the NHIF and the patient by a health insurance 
scheme. Due to this cost sharing, patients are not motivated to 
hide any drug consumption from the NHIF (Gaál et al., 2011). 
Thus, its data on prescribed and dispensed drugs are reliable and 
can be used to assess adherence to medications in a nationally 
representative manner. The statistical power could be ensured by 
the applied design being strong.
Although drug dispensing estimation is an objective process 
and is considered the most reliable method for assessing 
adherence in integrated healthcare systems, this approach cannot 
address other aspects of adherence (drug application according 
to the prescribed regime). In fact, our study gives an idea of 
patient’s initial decision to remain on prescribed medications. 
Furthermore, many important factors that can influence 
adherence, such as side effects, comorbidity and polypharmacy, 
access to healthcare, and patient attitudes, were not available 
through the analyzed database and were not included in our study 
model, which restricts the convincing power of the observed 
associations, obviously. Further research with more explanatory 
parameters is required to improve the relevance of our findings. 
Finally, our observations need confirmation by studies with 
individual-level data on patient characteristics.
CONClUSIONS
More than one-third of the written prescriptions of GPs for 
adults were not dispensed in Hungary. This high level of 
nonadherence was realized with a wide variability across GMPs 
can be explained by structural characteristics of GMPs, the 
socioeconomic status of patients provided, and the quality of 
cooperation between patients and GPs. Moreover, our findings 
suggest that the use of the dispensed-to-prescribed medication 
ratio in routine monitoring of primary health care can effectively 
support the necessary interventions. Since we have determined 
an alarmingly high level of nonadherence across the country, and 
given that nonadherence has a multifactorial etiology, our study 
urges further investigations to determine the main obstacles to 
primary nonadherence.
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